(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,296.31%434.78K | -71.09%6.35K | -518.30%-401.68K | 43.99%-162.94K | -108.80%-83.61K | 33.77%-36.34K | 121.57%21.98K | 30.97%-64.97K | 30.09%-290.92K | 9.74%-40.04K |
Net income from continuing operations | 191.48%65.55K | 224.84%94.71K | -122.04%-44.95K | -127.07%-1.03M | -336.69%-862.99K | -8.33%-71.66K | 15.32%-75.86K | 79.87%-20.24K | 16.17%-453.93K | -253.40%-197.62K |
Depreciation and amortization | 11,106.69%35.19K | 1,722.42%8.13K | --0 | -49.75%12.68K | -50.16%10.67K | -44.82%314 | -66.44%446 | -35.15%1.25K | 248.85%25.24K | 195.99%21.42K |
Asset impairment expenditure | ---- | ---- | ---- | 404.01%745.06K | ---- | ---- | ---- | ---- | --147.83K | ---- |
Other non cashItems | 4.25%491 | 4.47%491 | 4.68%492 | 4.44%1.88K | 11.93%469 | 0.00%471 | 2.17%470 | 4.44%470 | 4.41%1.8K | -13.96%419 |
Change In working capital | 866.05%333.55K | -200.05%-96.97K | -669.20%-357.23K | 1,012.58%108.19K | 291.84%23.18K | 237.41%34.53K | 787.34%96.92K | -1,234.09%-46.44K | 88.62%-11.86K | -142.85%-12.08K |
-Change in receivables | 12,867.70%70.35K | -346.20%-133.68K | 91.72%-2.21K | 243.93%24.24K | 86.44%-2.83K | -105.28%-551 | 4,825.76%54.3K | -403.30%-26.68K | -51.15%-16.84K | -152.34%-20.83K |
-Change in prepaid assets | 3,897.12%278.64K | 2.81%-5.75K | -10,715.08%-340.74K | 82.30%-1.56K | 39.52%-5.83K | --6.97K | ---5.92K | 292.42%3.21K | -977.38%-8.81K | -172.15%-9.63K |
-Change in payables and accrued expense | -154.94%-15.44K | -12.52%42.46K | 37.87%-14.27K | 519.50%85.5K | 73.21%31.83K | 14,224.12%28.11K | 474.76%48.54K | -367.79%-22.97K | 114.97%13.8K | -20.46%18.38K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,296.31%434.78K | -71.09%6.35K | -518.30%-401.68K | 43.99%-162.94K | -108.80%-83.61K | 33.77%-36.34K | 121.57%21.98K | 30.97%-64.97K | 30.09%-290.92K | 9.74%-40.04K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 49.60%-86.93K | 0 | ||||||
Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 49.60%-86.93K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 49.60%-86.93K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 500K | 0 | ||||||||
Net common stock issuance | ---- | ---- | ---- | --500K | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --500K | ---- | ---- | ---- | ---- | --0 | ---- |
Net cash flow | ||||||||||
Beginning cash position | -29.27%36.91K | 1.15%30.55K | 354.16%432.24K | -79.88%95.17K | -88.29%15.84K | -72.55%52.18K | -89.65%30.21K | -78.22%95.17K | 38,608.18%473.01K | -47.60%135.21K |
Current changes in cash | 223.70%44.96K | -71.09%6.35K | -518.30%-401.68K | 189.21%337.06K | 1,139.95%416.4K | 33.77%-36.34K | 115.94%21.98K | 55.21%-64.97K | -180.09%-377.84K | -118.62%-40.04K |
End cash Position | 416.81%81.86K | -29.27%36.91K | 1.15%30.55K | 354.16%432.24K | 354.16%432.24K | -88.29%15.84K | -72.55%52.18K | -89.65%30.21K | -79.88%95.17K | -79.88%95.17K |
Free cash from | 223.70%44.96K | -71.09%6.35K | -518.30%-401.68K | 56.88%-162.94K | -108.80%-83.61K | 33.77%-36.34K | 121.57%21.98K | 64.11%-64.97K | 35.81%-377.84K | 69.78%-40.04K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.